Alto Neuroscience Inc. (ANRO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alto Neuroscience Inc.

    NYSE: ANRO · Real-Time Price · USD
    6.62
    -0.27 (-3.92%)
    At close: Oct 06, 2025, 12:28 PM

    Alto Neuroscience Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -61.43M -36.3M -27.71M -9.19M
    Depreciation & Amortization
    		 502K 373K 342K 145K
    Stock-Based Compensation
    		 7.63M 2.89M 1.76M 227K
    Other Working Capital
    		 3.54M -391K 2.42M 255K
    Other Non-Cash Items
    		 1.81M 291K 632K 125K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 4.06M -698K 4.58M -572K
    Operating Cash Flow
    		 -47.42M -33.45M -20.39M -9.26M
    Capital Expenditures
    		 -2.08M -470K -732K -680K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -2.08M -470K -732K -680K
    Debt Repayment
    		 1.25M n/a 9.82M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -3.14M -2.05M -341K n/a
    Financial Cash Flow
    		 135.69M 68.13M 43.79M 31.69M
    Net Cash Flow
    		 86.18M 34.2M 22.64M 21.7M
    Free Cash Flow
    		 -49.5M -33.92M -21.13M -9.94M

    Add to Watchlist